Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

PURPOSE: Population studies have suggested that metformin use in diabetic patients decreases cancer incidence and mortality. Metformin inhibits the growth of cancer cells in vitro and tumors in vivo. However, there is little clinical data to support this. Our purpose was to determine whether metform...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jiralerspong, Sao, Palla, Shana L., Giordano, Sharon H., Meric-Bernstam, Funda, Liedtke, Cornelia, Barnett, Chad M., Hsu, Limin, Hung, Mien-Chie, Hortobagyi, Gabriel N., Gonzalez-Angulo, Ana M.
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2009
Sujets:
Original Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2736070/
https://ncbi.nlm.nih.gov/pubmed/19487376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.19.6410
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires